3 Great Mutual Fund Picks for Your Retirement
The easiest way to judge a mutual fund's quality over time is by analyzing its performance, diversification, and fees. Using the Zacks Mutual Fund Rank of over 19,000 mutual funds, we've identified three outstanding mutual funds that are ideally suited to help long-term investors pursue and achieve their retirement investing goals.
Let's learn about some of Zacks' highest ranked mutual funds with low fees you may want to consider.
If you are looking to diversify your portfolio, consider
(CGNCX). CGNCX is part of the Large Cap Blend section, and these mutual funds most often invest in firms with a market capitalization of $10 billion or more. By investing in bigger companies, these funds offer more stability, and are often well-suited for investors with a "buy and hold" mindset. This fund is a winner, boasting an expense ratio of 1.12%, management fee of 0%, and a five-year annualized return track record of 9.93%.
(JAGRX). Expense ratio: 0.67%. Management fee: 0.47%. JAGRX is a Large Cap Growth mutual fund, and these funds invest in many large U.S. firms that are projected to grow at a faster rate than their large-cap peers. This fund has managed to produce a robust 15.62% over the last five years.
(JNUSX) is an attractive large-cap allocation. JNUSX is a Non US - Equity fund. Many of these funds like to allocate across emerging and developed markets, and will often focus on all cap levels. JNUSX has an expense ratio of 0.65%, management fee of 0.55%, and annual returns of 17.31% over the past five years.
These examples highlight the fact that there are some astonishingly good mutual funds out there. If your advisor has you in the good ones, bravo! If not, you may need to have a talk.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Get Your Free (CGNCX): Fund Analysis Report
Get Your Free (JAGRX): Fund Analysis Report
Get Your Free (JNUSX): Fund Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
23 minutes ago
- Business Wire
Deadline Soon: 3D Systems Corporation (DDD) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
LOS ANGELES--(BUSINESS WIRE)-- The Law Offices of Frank R. Cruz reminds investors of the upcoming deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired 3D Systems Corporation ('3D Systems' or the 'Company') (NYSE: DDD) securities between August 13, 2024 and May 12, 2025, inclusive (the 'Class Period'). IF YOU ARE AN INVESTOR WHO LOST MONEY ON 3D SYSTEMS CORPORATION (DDD), CLICK HERE TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT. What Happened? On March 26, 2025, 3D Systems released its fourth quarter and full year 2024 financial results, missing consensus estimates in non-GAAP earnings-per-share and sales revenue, citing 'lowers hardware systems sales due to macroeconomic factors that are negatively impacting demand.' The Company also reported a '$9 million revenue reduction in Q4 driven by a change in accounting estimates for [the Company's] Regenerative Medicine program." The Company disclosed that "[t]his change in estimate [was] related to the now anticipated use of pre-clinical human decedent testing . . . which led to refinement of the milestone technical criteria." On this news, 3D Systems' stock price fell $0.57, or 21%, to close at $2.15 per share on March 27, 2025, thereby injuring investors. Then, on May 12, 2025, after market hours, 3D Systems released its first quarter 2025 financial results, missing consensus estimates due, in part, to a decline in material sales, mostly due to inventory management issues in the dental portion of its Healthcare Solutions segment. The Company further disclosed that it was withdrawing its full-year 2025 outlook, citing prolonged softness in customer capital spending and macroeconomic uncertainty. On this news, 3D Systems' stock price fell $0.68, or 26.6%, to close at $1.87 per share on May 13, 2025, thereby injuring investors further. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) 3D Systems had understated the impact of weakened customer spending on the Company's business, while overstating its resilience in challenging industry conditions; (2) the updated milestone criteria in the United Partnership would negatively impact the Company's Regenerative Medicine Program revenue; and (3) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. If you purchased or otherwise acquired 3D Systems securities between August 13, 2024 and May 12, 2025, the deadline to seek appointment as the lead plaintiff in the securities fraud class action is August 12, 2025. Contact Us To Participate or Learn More: If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact us: Frank R. Cruz The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 Email us at: info@ Call us at: 310-914-5007 Visit our website at Follow us for updates on Twitter: If you inquire by email, please include your mailing address, telephone number, and number of shares purchased. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Yahoo
an hour ago
- Yahoo
UBS: Time to cut back on cyclicals, favor select defensives
-- UBS said in a note Friday that investors should scale back exposure to most cyclical stocks outside of a few favored areas, citing weakening macro trends, stretched valuations, and seasonal underperformance risks. 'We are overweight financials and tech, electrification and domestic European consumer,' UBS strategists wrote, but stressed it is 'appropriate to lighten up on cyclicals outside of these areas in general.' The firm expects U.S. domestic demand to slow sharply, from 2.3% year-over-year in Q2 to 0.5% in Q4, and forecasts the U.S. 10-year yield at 3.8% by year-end. Historically, cyclicals have underperformed 84% of the time when volatility rises, UBS noted. Valuations are seen as another concern. The price-to-earnings ratio of cyclicals (excluding tech and financials) is '1.8 standard deviations above its norm in Europe and 1.4 standard deviations above in the U.S.' Meanwhile, the bank said most cyclical segments are crowded, with only paper and transport screens notably cheap. UBS recommends increasing exposure to defensive sectors with 'high profitability but low volatility of CFROI,' highlighting beverages, healthcare equipment, household products, select utilities, software, and non-U.S. defense. "Defensive sectors that score well on our screens are: beverages (we are benchmark), healthcare equipment (overweight) and household products (move to overweight)," the bank wrote. "Our preferred defensive sectors remain: parts of utilities, healthcare equipment, software and flavouring companies, non-US defence (India, Japan), European telecoms and UK food retailing." They highlighted names such as Alcon (NYSE:ALC), Abbot, DSM, Boston Scientific (NYSE:BSX), Orange, DT, BAE Systems (LON:BAES), Tesco (OTC:TSCDY), MSFT, SAP, Air Liquide (OTC:AIQUY), ENEL, ELIA, RWE (LON:0HA0), Entergy (NYSE:ETR), NiSource (NYSE:NI) and ConvaTec. The firm has raised household products to overweight, calling the European sector 'abnormally cheap against food' and noting its resilience and emerging market revenue exposure. Healthcare equipment is also a top pick. 'Price momentum is now 15% below its 6-month moving average… more than at any point in the past decade,' UBS said, adding that valuations are at a rare discount and earnings revisions are strong. Conversely, UBS advises trimming capital goods in the near term, warning they are 'very overbought' with a sharp disconnect between performance and earnings trends. Related articles UBS: Time to cut back on cyclicals, favor select defensives Victoria's Secret Exposed: The Warning Sign Behind the Stock's 52% Collapse Apollo economist warns: AI bubble now bigger than 1990s tech mania Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
an hour ago
- Yahoo
Here's Why Vertiv Holdings Co. (VRT) is a Strong Momentum Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to use the Zacks Style Scores, which are indicators that rate stocks based on three widely-followed investing types: value, growth, and momentum. Is This 1 Momentum Stock a Screaming Buy Right Now? Different than value or growth investors, momentum-oriented investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks. Vertiv Holdings Co. (VRT) Vertiv is a leading global provider of critical digital infrastructure and services for data centers, communication networks, and commercial and industrial environments. Vertiv serves essential industries, including cloud computing, financial services, healthcare, transportation, manufacturing, energy, government, education, retail and social media. VRT sits at a Zacks Rank #3 (Hold), holds a Momentum Style Score of A, and has a VGM Score of B. The stock is down 4.3% and up 15.5% over the past one-week and four-week period, respectively, and Vertiv Holdings Co. has gained 96.2% in the last one-year period as well. Additionally, an average of 7,917,655 shares were traded over the last 20 trading sessions. Momentum investors don't just pay attention to price changes; positive earnings play a crucial role, too. Five analysts revised their earnings estimate upwards in the last 60 days for fiscal 2025. The Zacks Consensus Estimate has increased $0.21 to $3.76 per share. VRT boasts an average earnings surprise of 10.7%. VRT should be on investors' short list because of its impressive earnings fundamentals, a good Zacks Rank, and strong Momentum and VGM Style Scores. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Vertiv Holdings Co. (VRT) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
